Search research articles
Contact Us
Filters
Showing results (41-50 of 66) with videos related to
Page
of 7
Sort By:
Journal of the National Cancer Institute
|
April 1, 1974
Biologic characteristics of transformed rhesus foreskin cells infected with Mason-Pfizer monkey virus
D L Fine, R J Peinta, L B Malan, et al.
Transplantation and Cellular Therapy
|
July 23, 2022
Monitoring Neurocognitive Functioning After Pediatric Cellular Therapy or Hematopoietic Cell Transplant: Guidelines From the COG Neurocognition in Cellular Therapies Task Force
Hannah-Lise T Schofield, Vanessa A Fabrizio, Suzanne Braniecki, et al.
Nature
|
December 19, 2008
WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activity
Andrew Xiao, Haitao Li, David Shechter, et al.
The Journal of Biological Chemistry
|
January 27, 2005
DRAGON, a bone morphogenetic protein co-receptor
Tarek A Samad, Anuradha Rebbapragada, Esther Bell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2021
Multicenter Analysis of Genomically Targeted Single Patient Use Requests for Pediatric Neoplasms
Himalee S Sabnis, David S Shulman, Benjamin Mizukawa, et al.
Bone Marrow Transplantation
|
May 12, 2020
Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant
Vanessa A Fabrizio, Nancy A Kernan, Farid Boulad, et al.
Journal of Gastrointestinal Oncology
|
August 29, 2018
Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition
David A Fabrizio, Thomas J George, Richard F Dunne, et al.
Nature Medicine
|
April 15, 2022
Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial
Edward S Kim, Vamsidhar Velcheti, Tarek Mekhail, et al.
The Journal of Molecular Diagnostics : JMD
|
August 25, 2019
A Novel Next-Generation Sequencing Approach to Detecting Microsatellite Instability and Pan-Tumor Characterization of 1000 Microsatellite Instability-High Cases in 67,000 Patient Samples
Sally E Trabucco, Kyle Gowen, Sophia L Maund, et al.
The Lancet. Oncology
|
September 13, 2020
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
Aurélien Marabelle, Marwan Fakih, Juanita Lopez, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 66) with videos related to
Sort By:
Page
of 7
Journal of the National Cancer Institute
|
April 1, 1974
Biologic characteristics of transformed rhesus foreskin cells infected with Mason-Pfizer monkey virus
D L Fine, R J Peinta, L B Malan, et al.
Transplantation and Cellular Therapy
|
July 23, 2022
Monitoring Neurocognitive Functioning After Pediatric Cellular Therapy or Hematopoietic Cell Transplant: Guidelines From the COG Neurocognition in Cellular Therapies Task Force
Hannah-Lise T Schofield, Vanessa A Fabrizio, Suzanne Braniecki, et al.
Nature
|
December 19, 2008
WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activity
Andrew Xiao, Haitao Li, David Shechter, et al.
The Journal of Biological Chemistry
|
January 27, 2005
DRAGON, a bone morphogenetic protein co-receptor
Tarek A Samad, Anuradha Rebbapragada, Esther Bell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2021
Multicenter Analysis of Genomically Targeted Single Patient Use Requests for Pediatric Neoplasms
Himalee S Sabnis, David S Shulman, Benjamin Mizukawa, et al.
Bone Marrow Transplantation
|
May 12, 2020
Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant
Vanessa A Fabrizio, Nancy A Kernan, Farid Boulad, et al.
Journal of Gastrointestinal Oncology
|
August 29, 2018
Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition
David A Fabrizio, Thomas J George, Richard F Dunne, et al.
Nature Medicine
|
April 15, 2022
Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial
Edward S Kim, Vamsidhar Velcheti, Tarek Mekhail, et al.
The Journal of Molecular Diagnostics : JMD
|
August 25, 2019
A Novel Next-Generation Sequencing Approach to Detecting Microsatellite Instability and Pan-Tumor Characterization of 1000 Microsatellite Instability-High Cases in 67,000 Patient Samples
Sally E Trabucco, Kyle Gowen, Sophia L Maund, et al.
The Lancet. Oncology
|
September 13, 2020
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
Aurélien Marabelle, Marwan Fakih, Juanita Lopez, et al.
Page
of 7